• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植后死亡率的病因和风险因素的演变:NIDDK 长期随访研究的结果。

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.

出版信息

Am J Transplant. 2010 Jun;10(6):1420-7. doi: 10.1111/j.1600-6143.2010.03126.x. Epub 2010 May 10.

DOI:10.1111/j.1600-6143.2010.03126.x
PMID:20486907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2891375/
Abstract

Although mortality rates following liver transplantation (LT) are well described, there is a lack of detailed, prospective studies determining patterns of and risk factors for long-term mortality. We analyzed the multicenter, prospectively obtained The National Institute of Diabetes and Digestive and Kidney Diseases LT Database of 798 transplant recipients from 1990 to 1994 (follow-up 2003). Overall, 327 recipients died. Causes of death >1 year: 28% hepatic, 22% malignancy, 11% cardiovascular, 9% infection, 6% renal failure. Renal-related death increased dramatically over time. Risk factors for death >1 year (univariate): male gender, age/decade, pre-LT diabetes, post-LT diabetes, post-LT hypertension, post-LT renal insufficiency, retransplantation >1 year, pre-LT malignancy, alcoholic disease (ALD) and metabolic liver disease, with similar risks noted for death >5 years. Hepatitis C, retransplantation, post-LT diabetes, hypertension and renal insufficiency were significant risk factors for liver-related death. Cardiac deaths associated with age, male gender, ALD, cryptogenic disease, pre-LT hypertension and post-LT renal insufficiency. In summary, the leading causes of late deaths after transplant were graft failure, malignancy, cardiovascular disease and renal failure. Older age, diabetes and renal insufficiency identified patients at highest risk of poor survival overall. Diligent management of modifiable post-LT factors including diabetes, hypertension and renal insufficiency may impact long-term mortality.

摘要

尽管肝移植(LT)后的死亡率已有很好的描述,但缺乏详细的前瞻性研究来确定长期死亡率的模式和危险因素。我们分析了 1990 年至 1994 年期间来自 1990 年至 1994 年的国家糖尿病、消化和肾脏疾病 LT 数据库(随访至 2003 年)的多中心、前瞻性获得的 798 例移植受者。总体而言,有 327 例受者死亡。1 年以上死因:28%为肝性,22%为恶性肿瘤,11%为心血管,9%为感染,6%为肾功能衰竭。肾功能相关死亡随时间显著增加。1 年以上死亡的危险因素(单因素):男性,年龄/十年,LT 前糖尿病,LT 后糖尿病,LT 后高血压,LT 后肾功能不全,再移植>1 年,LT 前恶性肿瘤,酒精性疾病(ALD)和代谢性肝病,5 年以上死亡的风险相似。丙型肝炎、再移植、LT 后糖尿病、高血压和肾功能不全是与肝相关死亡的显著危险因素。与年龄、男性、ALD、隐源性疾病、LT 前高血压和 LT 后肾功能不全相关的心脏死亡。总之,移植后晚期死亡的主要原因是移植物衰竭、恶性肿瘤、心血管疾病和肾功能衰竭。年龄较大、糖尿病和肾功能不全使患者总体生存率最高的风险增加。对 LT 后可改变的因素(包括糖尿病、高血压和肾功能不全)进行严格管理可能会影响长期死亡率。

相似文献

1
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.肝移植后死亡率的病因和风险因素的演变:NIDDK 长期随访研究的结果。
Am J Transplant. 2010 Jun;10(6):1420-7. doi: 10.1111/j.1600-6143.2010.03126.x. Epub 2010 May 10.
2
Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.肝移植后影响肾功能的因素。国际观察性研究MOST的结果。
Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28.
3
Analysis of adult 20-year survivors after liver transplantation.肝移植术后成年20年幸存者的分析。
Hepatol Int. 2015 Jul;9(3):461-70. doi: 10.1007/s12072-014-9577-x. Epub 2014 Sep 18.
4
Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors.肝移植:免疫抑制、肾功能不全及心血管危险因素的作用
Minerva Chir. 2012 Feb;67(1):1-13.
5
Renal outcomes after liver transplantation in the model for end-stage liver disease era.终末期肝病模型时代肝移植后的肾脏结局
Liver Transpl. 2009 Sep;15(9):1142-8. doi: 10.1002/lt.21821.
6
The impact of post-transplant diabetes mellitus on liver transplant outcomes.移植后糖尿病对肝移植结局的影响。
Clin Transplant. 2019 Jun;33(6):e13554. doi: 10.1111/ctr.13554. Epub 2019 Apr 23.
7
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.肝移植后心血管疾病的发病率和死亡率:霉酚酸酯的保护作用。
Liver Transpl. 2017 Apr;23(4):498-509. doi: 10.1002/lt.24738.
8
Cardiovascular mortality in liver and kidney transplant recipients: A retrospective analysis from a single institution.肝、肾移植受者的心血管死亡率:单中心回顾性分析。
Medicine (Baltimore). 2021 May 21;100(20):e26019. doi: 10.1097/MD.0000000000026019.
9
Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.肾功能损害对非酒精性脂肪性肝炎肝硬化患者肝移植后心血管疾病死亡率的影响。
Liver Int. 2015 Dec;35(12):2575-83. doi: 10.1111/liv.12872. Epub 2015 Jun 3.
10
Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.减少他克莫司用量可降低肝移植后新发糖尿病的风险。
World J Gastroenterol. 2016 Feb 14;22(6):2133-41. doi: 10.3748/wjg.v22.i6.2133.

引用本文的文献

1
Incidence and Risk Factors for Progression of Acute Kidney Injury to Chronic Kidney Disease After Liver Transplantation: A Retrospective Cohort Study.肝移植后急性肾损伤进展为慢性肾脏病的发病率及危险因素:一项回顾性队列研究
FASEB J. 2025 Sep 15;39(17):e70903. doi: 10.1096/fj.202500546R.
2
Predicting post-liver transplantation mortality: a retrospective cohort study on risk factor identification and prognostic nomogram construction.预测肝移植术后死亡率:一项关于危险因素识别和预后列线图构建的回顾性队列研究。
Eur J Med Res. 2025 Aug 20;30(1):772. doi: 10.1186/s40001-025-03021-4.
3
Female liver transplant recipients are at increased risk of developing cervical cancer: A global multicenter study.

本文引用的文献

1
Long-term probability of and mortality from de novo malignancy after liver transplantation.肝移植后新发恶性肿瘤的长期概率及死亡率。
Gastroenterology. 2009 Dec;137(6):2010-7. doi: 10.1053/j.gastro.2009.08.070. Epub 2009 Sep 18.
2
Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.美国病毒性肝炎肝移植等待名单登记趋势。
Gastroenterology. 2009 Nov;137(5):1680-6. doi: 10.1053/j.gastro.2009.07.047. Epub 2009 Jul 24.
3
The hepatitis C virus-associated dysmetabolic syndrome.
女性肝移植受者患宫颈癌的风险增加:一项全球多中心研究。
Indian J Gastroenterol. 2025 Jul 22. doi: 10.1007/s12664-025-01842-z.
4
Allogeneic Liver Transplantation in Nonhuman Primates: Surgical Technique With Stable Postoperative Outcomes.非人灵长类动物的同种异体肝移植:具有稳定术后结果的手术技术
Transplant Direct. 2025 Jun 27;11(7):e1832. doi: 10.1097/TXD.0000000000001832. eCollection 2025 Jul.
5
Insights and perspectives: EUS in post-liver transplantation care.见解与观点:内镜超声在肝移植术后护理中的应用
Endosc Ultrasound. 2024 Sep-Oct;13(5):283-286. doi: 10.1097/eus.0000000000000084. Epub 2024 Nov 5.
6
Advances and challenges in the application of donor-derived cell-free DNA for diagnosis and treatment in liver transplantation: a narrative review.供体来源的游离DNA在肝移植诊断和治疗中的应用进展与挑战:一篇叙述性综述
BMC Surg. 2025 May 13;25(1):203. doi: 10.1186/s12893-025-02911-y.
7
The Prevalence and Characteristics of Infective Endocarditis in Liver Transplant Recipients: Insights From National Inpatient Sample Database.肝移植受者感染性心内膜炎的患病率及特征:来自国家住院样本数据库的见解
Clin Cardiol. 2025 Apr;48(4):e70130. doi: 10.1002/clc.70130.
8
Side Effects of Immunosuppressant Drugs After Liver Transplant.肝移植后免疫抑制药物的副作用
Pharmaceuticals (Basel). 2025 Feb 27;18(3):342. doi: 10.3390/ph18030342.
9
Ramadan Fasting and Complications of Metabolic Dysfunction-Associated Steatotic Liver Disease: Impacts on Liver Cirrhosis and Heart Failure.斋月禁食与代谢功能障碍相关脂肪性肝病的并发症:对肝硬化和心力衰竭的影响。
J Clin Med. 2025 Mar 9;14(6):1841. doi: 10.3390/jcm14061841.
10
Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation.肝脏移植评估的视角与工具:肝脏移植的变革时代
Biomedicines. 2025 Feb 17;13(2):494. doi: 10.3390/biomedicines13020494.
Hepatology. 2008 Sep;48(3):1018-9; author reply 1019. doi: 10.1002/hep.22425.
4
Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation.肝移植术后一年内发生移植后糖尿病的预测因素。
Transplantation. 2008 May 27;85(10):1436-42. doi: 10.1097/TP.0b013e31816f1b7c.
5
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database.肥胖对肝移植受者长期预后的影响——美国国立糖尿病、消化和肾脏疾病研究所肝移植数据库的结果
Am J Transplant. 2008 Mar;8(3):667-72. doi: 10.1111/j.1600-6143.2007.02100.x.
6
Improving outcomes of liver retransplantation: an analysis of trends and the impact of Hepatitis C infection.改善肝脏再次移植的预后:趋势分析及丙型肝炎感染的影响
Am J Transplant. 2008 Feb;8(2):404-11. doi: 10.1111/j.1600-6143.2007.02082.x.
7
Long-term results after liver transplantation.肝移植后的长期结果。
Transpl Int. 2008 Mar;21(3):234-46. doi: 10.1111/j.1432-2277.2007.00596.x. Epub 2007 Nov 21.
8
Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up.新发糖尿病对肝移植术后患者及移植物存活的负面影响:长期随访
Transplantation. 2006 Dec 27;82(12):1625-8. doi: 10.1097/01.tp.0000250361.60415.96.
9
The burden of new-onset diabetes mellitus after transplantation.移植后新发糖尿病的负担。
Clin Transplant. 2006 Nov-Dec;20(6):755-61. doi: 10.1111/j.1399-0012.2006.00565.x.
10
Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience.679例连续肝移植受者的晚期死亡率:哥德堡肝移植经验
Transplant Proc. 2006 Oct;38(8):2671-2. doi: 10.1016/j.transproceed.2006.07.029.